CD40 and neoplasm: However, research documented that α-GalCer combined with agonistic anti-DR5 and anti-4-1BB antibodies or agonistic anti-CD40 and anti-4-1BB antibodies significantly led to tumor regression, and about 80% of mice underwent complete regression [215, 216].